US5034220A - Non-aerosol shaving gel - Google Patents

Non-aerosol shaving gel Download PDF

Info

Publication number
US5034220A
US5034220A US07/540,990 US54099090A US5034220A US 5034220 A US5034220 A US 5034220A US 54099090 A US54099090 A US 54099090A US 5034220 A US5034220 A US 5034220A
Authority
US
United States
Prior art keywords
weight
water
gel composition
shaving gel
aerosol shaving
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
US07/540,990
Inventor
Michael W. Helioff
Mohammed Tazi
Robert B. Login
John F. Tancredi
Stephen L. Kopolow
William J. Burlant
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
VERONA Inc A DE CORP
Original Assignee
GAF Chemicals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GAF Chemicals Corp filed Critical GAF Chemicals Corp
Assigned to GAF CHEMICALS CORPORATION reassignment GAF CHEMICALS CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST. Assignors: TANCREDI, JOHN F., BURLANT, WILLIAM J., KOPOLOW, STEPHEN L., LOGIN, ROBERT B., HELIOFF, MICHAEL W., TAZI, MOHAMMED
Priority to US07/540,990 priority Critical patent/US5034220A/en
Assigned to CHASE MANHATTAN BANK (NATIONAL ASSOCIATION), THE reassignment CHASE MANHATTAN BANK (NATIONAL ASSOCIATION), THE SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GAF CHEMICALS CORPORATION, A CORP. OF DE
Priority to EP91909246A priority patent/EP0581764A1/en
Priority to AU78511/91A priority patent/AU7851191A/en
Priority to CA002082829A priority patent/CA2082829A1/en
Priority to PCT/US1991/002945 priority patent/WO1991019477A1/en
Assigned to CREATIVE TECHNOLOGIES GROUP, INC. reassignment CREATIVE TECHNOLOGIES GROUP, INC. ASSIGNMENT OF ASSIGNORS INTEREST. Assignors: GAF CHEMICALS CORPORATION, A CORPORATION OF DE
Publication of US5034220A publication Critical patent/US5034220A/en
Application granted granted Critical
Assigned to VERONA INC. A DE CORP. reassignment VERONA INC. A DE CORP. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). EFFECTIVE ON 03/30/1992 Assignors: CREATIVE TECHNOLOGIES GROUP, INC.
Assigned to GAF BUILDING MATERIALS CORPORATION, GAF CHEMICALS CORPORATION, SUTTON LABORATORIES, INC. reassignment GAF BUILDING MATERIALS CORPORATION RELEASED BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: CHASE MANHATTAN BANK, THE (NATIONAL ASSOCIATION)
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/042Gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • A61K8/585Organosilicon compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8164Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical, and containing at least one other carboxyl radical in the molecule, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers, e.g. poly (methyl vinyl ether-co-maleic anhydride)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q9/00Preparations for removing hair or for aiding hair removal
    • A61Q9/02Shaving preparations

Definitions

  • This invention relates to non-aerosol shaving gels, and, more particularly, to such shaving preparations which have advantageous properties during use.
  • U.S. Pat. No. 3,541,581 describes a post-foaming aerosol gel as a shaving preparation which consisted of an aqueous dispersion of a soap, a water-soluble gelling aid, and a post-foaming agent having a high vapor pressure at room temperature.
  • the product was discharged from an aerosol container as a stable gel and the foam was developed in situ on the surface of the skin by vaporization of the low boiling point agent.
  • U.S. Pat. No. 3,314,857 describes a transparent shaving cream with good lubricating properties which deposited a skin protective layer and which did not emulsify the natural skin oils.
  • the composition included a polydimethyl siloxane, a crosslinked, water-soluble polyacrylic acid, triethanolamine, and a non-ionic surfactant.
  • U.S. Pat. No. 4,046,874 describes a shaving cream adapted for dry shaving using a conventional razor blade comprising an aqueous foam containing in the aqueous phase a polyglycerol ester such as triglycerol monostearate and a texturizing amount of a water-insoluble pulverulent bodying agent such as sodium silicoaluminate.
  • An object of the present invention is to provide a non-aerosol shaving gel formulation which can provide effective razor glide, lubricity, creaminess and which leaves a protective film on the skin of the user.
  • Another object herein is to provide a hydrophobic crosslinked, neutralized maleic anhydride-C 1 -C 5 alkyl vinyl ether copolymer, water-soluble soap in a gel composition for use as a non-aerosol shaving preparation.
  • Still another object herein is to provide a non-aerosol shaving gel composition which is particularly useful for sensitive skin which are characterized by a plurality of small bumps over its entire surface such as is frequently encountered by black males.
  • the non-aerosol shaving gel formulation of the invention consists essentially of a major amount of a resin gel-former which is a crosslinked, neutralized maleic anhydride-C 1 -C 5 alkyl vinyl ether copolymer, a water-soluble soap and water.
  • a resin gel-former which is a crosslinked, neutralized maleic anhydride-C 1 -C 5 alkyl vinyl ether copolymer, a water-soluble soap and water.
  • Other ingredients are advantageously included in the formulation. Accordingly, the essential and preferred components of the composition of the invention includes the following:
  • a resin gel-former i.e. a water-soluble salt of a crosslinked, neutralized Gantrez® copolymer
  • a soap i.e. a water-soluble salt of a high molecular weight fatty acid
  • a lubricant preferably a polyvinylpyrrolidone (PVP)-silicone composite
  • miscellaneous additives such as humectants, emulsifiers, preservatives, skin conditioners, surfactants, and/or fragrances.
  • the non-aerosol shaving gel formulation of the invention provides the following features for the user:
  • the amount of water therein is reduced accordingly.
  • the crosslinked, neutralized Gantrez® copolymer component of the composition of the invention is a maleic anhydride-C 1 -C 5 alkyl vinyl ether copolymer neutralized with sodium hydroxide or potassium hydroxide.
  • a preferred crosslinked Gantrez® is a copolymer of maleic anhydride and methyl vinyl ether crosslinked with about 1 to about 5 mole percent based on the monovinyl alkyl ether of a crosslinking agent.
  • Suitable crosslinking agents include 1,9-decadiene, 1,7-octadiene, divinyl benzene, the divinyl ethers of an aliphatic diol acrylamides, acrylates and the like.
  • the crosslinked, neutralized Gantrez® component suitably comprises about 0.2-5% by weight of the composition. Low percentages provide a relatively thin composition while high percentages will produce a relatively thick gel.
  • the crosslinked, neutralized Gantrez® component in the composition provides the resinous structure of the gel and forms a film on the skin both before and during shaving.
  • the soap component is a water-soluble salt of a higher fatty acid, i.e. C 10 -C 24 fatty acids.
  • Soaps are well known in the art and may be prepared in any conventional manner.
  • soaps may be prepared by reacting a basic material such as triethanolamine directly with a higher fatty acid such as stearic, palmitic, myristic, oleic, coconut oil fatty acids, soya oil fatty acids, and mixtures of these acids.
  • soaps include the water-soluble stearate and palmitate soaps, such as the potassium, ammonium, and soluble amine soaps of commercial stearic acid and palmitic acid.
  • the triethanolamine and morpholine soaps of these acids are preferred.
  • the product sold commercially as stearic acid is actually a mixture consisting primarily of stearic and palmitic acids.
  • stearates is used herein to designate soaps of commercial stearic acid, although soaps of chemically pure stearic acid would be the equivalent for the purposes of this invention.
  • the soaps may be made by neutralization of the appropriate higher fatty acid with suitable alkali, or may be introduced in the form of animal fats, such as tallow, or vegetable fats, such as palm oil, which are rich in the appropriate acid and which, when saponified, form soaps rich in the corresponding acid.
  • the amount of soap employed to form the gel generally depends upon the nature of the soap used.
  • the low limit is the minimum amount which gives a satisfactory gel, and the upper limit is fixed either by economic considerations or by the amount which will form a suitable gel as the highest temperatures likely to be encountered in use.
  • the beneficial effects of the instant invention are achieved to an optimum degree when the composition contains an appreciable amount of soap, such as specified within the preferred range.
  • the function of the soap in the composition of the invention is to fill up the pores of the resinous structure of the gel provided by the crosslinked Gantrez®.
  • soap aids the wetting characteristics of the preparations described.
  • the water in the composition of the present invention is requisite for the preparation of a suitable gel having desirable shaving properties. It has been found that water (tap water, distilled water, deionized water, etc.) possesses adequate solubility for the soap and has the required compatibility with the resin to produce stable gels of the invention. In general, relatively small amounts of polar substances, such as lower molecular weight alcohols, methanol, ethanol, propanol, isopropanol, and the like may be used; the only requirement being that sufficient water be present to maintain the desired physical characteristic of the gel. Generally, the amount of water employed in the gel may be varied depending upon the properties desired in the final product. The amount of water employed depends on the nature of the soap and resin used.
  • At least about 80 percent and preferably from about 80 to about 95 percent by weight of the total gel composition should be water although higher amounts may be employed if desired, e.g., up to about 97 percent by weight of the total composition.
  • the upper limit is the maximum amount that produces a satisfactory gel at the temperatures likely to be encountered in use, while the lower limit is fixed substantially by economic considerations.
  • the lubricant in the composition of the invention contributes to the comfort, closeness and speed of wet shaving. It is known in the art to use polysiloxanes and polysilicone fluids for their lubricating properties and these may be included in the composition of the invention for this purpose. Mineral oils, lanolin or isopropyl myristate also can be included to supplement the effects of the free fatty acid. Water-soluble polymers such as polyvinylpyrrolidone, sodium carboxymethyl cellulose or polyacrylic acid and its derivatives, can also improve lubrication and/or skin irritation caused by other compounds.
  • This lubricant composition includes individual droplets of a non-volatile silicone fluid encapsulated within a thin film of polyvinylpyrrolidone. These discrete droplets of encapsulated silicone fluid can be maintained as a stable dispersion or as a separate layer in an aqueous medium by controlling the viscosity of the solution.
  • This composition is prepared by dispersing the non-volatile silicone fluid in an aqueous medium containing a vinylpyrrolidone monomers optionally including other monomers to be copolymerized therewith, and polymerizing the vinylpyrrolidone monomer in situ while maintaining the integrity of the silicone fluid dispersion. This results in the formation of a thin film (shell) of polyvinylpyrrolidone surrounding the individual dispersed particles of the silicone fluid (core).
  • a vinylpyrrolidone monomers optionally including other monomers to be copolymerized therewith
  • Suitable non-volatile silicone fluids used in making these stabilized droplets may be either a polyalkyl siloxane, a polyaryl siloxane, a polyalkylaryl siloxane or a polyether siloxane copolymer, which are present at a level of from about 1.0% to about 18%.
  • the silicone fluid is present in an amount from about 2.0% to about 8.0%.
  • Mixtures of silicone fluids also may be used so long as the final mixture is non-volatile.
  • the dispersed silicone particles should also be insoluble in the medium. As used herein, the word "insoluble" means that it does not substantially dissolve in water and is essentially immiscible therewith.
  • Non-volatile polyalkylsiloxanes that may be used include, for example, polydimethylsiloxane with viscosities ranging from about 5-600,000 centistokes at 25° C.
  • the siloxanes are available, for example, from the General Electric Company as the VISCASIL series and from Dow Corning as the Dow Corning 200 series.
  • the viscosity can be measured by means of a glass capillary viscometer as set forth in Dow Corning Corporate Test Method CTM 0004 of July 20, 1970.
  • the viscosity ranges from about 350 centistokes to about 100,000 centistokes.
  • Non-volatile polyalkylarylsiloxanes that may be used include, for example, polymethylphenylsiloxanes having viscosities of from about 15-65 centistokes at 25° C. These siloxanes are available, for example, from the General Electric Company as SF 1075 methylphenyl fluid or from Dow Corning as 556 Cosmetic Grade Fluid. Additionally, poly(dimethylsiloxane)(diphenylsiloxane) copolymers having a viscosity in the range of from about 10-100,000 centistokes at 25° C. are useful.
  • Non-volatile polyethersiloxane copolymers suitable for use in the invention include, for example, a polypropylene oxide modified dimethylpolysiloxane, e.g., Dow Corning DC-1248, although ethylene oxide or mixtures of ethylene oxide and propylene oxide may also be used.
  • a polypropylene oxide modified dimethylpolysiloxane e.g., Dow Corning DC-1248
  • ethylene oxide or mixtures of ethylene oxide and propylene oxide may also be used.
  • Suitable silicones are disclosed in U.S. Pat. No. 2,826,551, 3,964,500, 4,364,837, and British Patent No. 849,433 to Woolston. The disclosures of these patents are incorporated herein by reference. In addition, the disclosure Silicone Compounds distributed by Petrarch Systems Inc., 1984, is incorporated by reference. This literature provides an extensive listing of suitable silicone materials.
  • the silicone fluid is added to water and subjected to agitation or high speed dispersion so as to produce a fine dispersion of discrete silicone fluid droplets throughout the aqueous medium.
  • a vinylpyrrolidone monomer is added to the mixture, along with an appropriate initiator. If desired, an additional monomer for purposes of forming a copolymer may be added.
  • Typical co-monomers include dimethylaminopropyl methacrylate, dimethylaminoethyl methacrylate, methacrylamidopropyltrimethylammonium chloride, acrylamide, and neutralized acrylic acid.
  • a suitable polymerization catalyst for vinylpyrrolidone is then added.
  • these catalysts are t-butylperoctoate, t-butylperoxypivalate, and the like.
  • Conventional catalysts for the polymerization of vinyl pyrrolidone are suitable.
  • the polymerization is carried out by maintaining the reaction mixture at a temperature in the range from about 55° to 85° C., preferably, from about 75° to 85° C., and most preferably, from about 78° to 82° C., for a period of time sufficient to produce the desired effect of providing a film about the discrete droplets of silicone fluid.
  • the amount of monomer to silicone fluid is in the range from about 95/5 to 5/95 on a weight basis. We have found that as the ratio becomes less than about 50/50, the production of a stable suspension is significantly decreased.
  • a stable suspension means that the discrete droplets of the silicone fluid remain suspended on standing for seven days at ambient temperature.
  • the amount of vinylpyrrolidone monomer to silicone fluid is preferably in the range from about 95/5 to 60/40. Most preferred is the range from about 90/10 to 80/20.
  • a viscosity of about 12,000 cps is suitable to maintain a stable suspension.
  • the particle size of the droplets are in the range from about 10 to 100 ⁇ , stability can be obtained at a viscosity of approximately 6,000 cps.
  • a dispersion of a silicone fluid (Dimethicone) was prepared by adding 10 grams of Dimethicone having a viscosity of 100 cs to a reactor kettle in 400 grams of distilled water. The mixture was stirred at 300 to 400 rpm to disperse the Dimethicone into discrete small droplets. The system was purged with nitrogen for 30 minutes.
  • the mixture was then heated to 80° C. and 0.25 grams of t-butylperoctoate was added. This temperature was maintained for 30 minutes with continuous stirring of the mixture.
  • the product obtained was a dispersion of minute droplets of the silicone fluid which remained suspended in the medium as a 90%-10% PVP:silicone composite containing 20% solids, i.e. 20 g. composite in 80 g. of water.
  • a humectant is included in the composition to prevent premature drying out of the gel.
  • the humectant also has the effect of making the gel softer.
  • Suitable humectants include polyols such as sorbitol, glycerol, propylene glycol, dipropylene glycol, 1,3-butylene glycol. Preferably a combination of up to about 28% by weight of sorbitol and up to about 8% by weight of propylene glycol is used in the composition of the invention.
  • the emulsifier or non-ionic surfactants that are useful for the purposes of the present invention are of the polyoxyethylene derivative type and are generally used in an amount equal to not more than 10% by weight of the composition.
  • ethers formed from long chain fatty alcohols and alkylene oxides are ethers formed by condensing lauryl alcohol with ethylene oxide.
  • Brij 30 is a liquid, oily product identified as polyoxyethylene (4) lauryl ether.
  • Brij 35 is a waxy, solid product designated as polyoxyethylene (23) lauryl ether. The numbers in parentheses indicate the number of oxyethylene groups in each polyether.
  • a suitable preservative may be used in the composition of the invention.
  • a preferred preservative is Germaben® sold by the Sutton Labs Div. of GAF Corporation, which is a mixture of diazolidinyl urea, methyl and propyl paraben, and propylene glycol.
  • wetting agents may also be used as the soap ingredient.
  • the wetting agents so employed preferably are anionic or non-ionic in character. They should be appreciably soluble in the aqueous components of the gel and of the type that produce foam in water solution. Examples of such agents are triethanolamine lauryl sulfate, sodium lauryl sulfate, sodium dodecyl benzene sulfonate, water-soluble polyoxyethylene ethers of alkyl-substituted phenols, and water-soluble polyoxyethylene cetyl ethers,.
  • anionic and nonionic wetting agents suitable for the purposes of the present invention are described in detail in McCutcheon's "Emulsifiers & Detergents Annual," 1967.
  • a wetting agent has been found to be effective in removing oily residue from the skin and in facilitating rinsing the lather from the skin.
  • the surfactant or wetting agent should be used in minor concentrations, preferably from about 3.0 percent to about 8 percent by weight of the gel.
  • a preferred surfactant is a non-ionic surfactant, such as Igepal® CO-630 (9 mole ethylene oxide), which is a preferred component in the composition of the invention.
  • composition is prepared by adding A-1 in A-3 to A-2, heating to 60°-70° C. for 5-10 minutes, cooling to 35°-40° C. with constant mixing, and then adding B-1 to B-6.
  • A-1 is a polyvinylmethylether-maleic anhydride copolymer.
  • B-1 is prepared according to the example above.
  • B-4 is a methylparaben-propylparaben.
  • B-5 is a nonoxynol.
  • composition above When used as a shaving preparation it is found that it provides a protective film on the skin which promotes effective razor glide, superior lubricity and a non-irritating feel on the skin, creaminess, and body, in a non-aerosol shaving gel which is convenient to use.

Abstract

A non-aerosol shaving gel of the invention consists essentially of a major amount of a resin gel-former which is a crosslinked, neutralized copolymer of maleic anhydride and a C1 -C5 alkyl vinyl ether, a water-soluble soap and water.

Description

BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to non-aerosol shaving gels, and, more particularly, to such shaving preparations which have advantageous properties during use.
2. Description of the Prior Art
U.S. Pat. No. 3,541,581 describes a post-foaming aerosol gel as a shaving preparation which consisted of an aqueous dispersion of a soap, a water-soluble gelling aid, and a post-foaming agent having a high vapor pressure at room temperature. The product was discharged from an aerosol container as a stable gel and the foam was developed in situ on the surface of the skin by vaporization of the low boiling point agent.
U.S. Pat. No. 3,314,857 describes a transparent shaving cream with good lubricating properties which deposited a skin protective layer and which did not emulsify the natural skin oils. The composition included a polydimethyl siloxane, a crosslinked, water-soluble polyacrylic acid, triethanolamine, and a non-ionic surfactant.
U.S. Pat. No. 4,046,874 describes a shaving cream adapted for dry shaving using a conventional razor blade comprising an aqueous foam containing in the aqueous phase a polyglycerol ester such as triglycerol monostearate and a texturizing amount of a water-insoluble pulverulent bodying agent such as sodium silicoaluminate.
These and other shaving soaps, creams, and aerosol foams, however, do very little in the way of acting as lubricants to assist the process of shaving. In addition, because they may contain ionic emulsifiers, they can emulsify protective skin oils, leaving the skin dry, unprotected and subject to irritation from the emulsifiers, the scraping action of the razor blade, and from sun, wind and perspiration.
For these reasons, present day shaving preparations do not address the special problems of the black-skinned male in removing facial hair. Since the facial hair of the black male is often curly and wiry, shaving such hairs leaves the exposed ends with sharp points and as the hairs regrow these sharp points can actually turn back onto and penetrate the skin, causing a clinical condition called "pseudofolliculitis barbae". For this reason, many black men do not shave but prefer to use a depilatory which can give a close "shave" and leave the hair tip soft and blunt so that it will not puncture and re-enter the skin.
An object of the present invention, therefore, is to provide a non-aerosol shaving gel formulation which can provide effective razor glide, lubricity, creaminess and which leaves a protective film on the skin of the user.
Another object herein is to provide a hydrophobic crosslinked, neutralized maleic anhydride-C1 -C5 alkyl vinyl ether copolymer, water-soluble soap in a gel composition for use as a non-aerosol shaving preparation.
Still another object herein is to provide a non-aerosol shaving gel composition which is particularly useful for sensitive skin which are characterized by a plurality of small bumps over its entire surface such as is frequently encountered by black males.
These together with other objects and advantages will become apparent from the following description.
SUMMARY OF THE INVENTION
The non-aerosol shaving gel formulation of the invention consists essentially of a major amount of a resin gel-former which is a crosslinked, neutralized maleic anhydride-C1 -C5 alkyl vinyl ether copolymer, a water-soluble soap and water. Other ingredients are advantageously included in the formulation. Accordingly, the essential and preferred components of the composition of the invention includes the following:
ESSENTIAL COMPONENTS
(1) a resin gel-former, i.e. a water-soluble salt of a crosslinked, neutralized Gantrez® copolymer;
(2) a soap, i.e. a water-soluble salt of a high molecular weight fatty acid; and
(3) a large amount of water.
PREFERRED COMPONENTS
(1) a lubricant, preferably a polyvinylpyrrolidone (PVP)-silicone composite; and
(2) miscellaneous additives such as humectants, emulsifiers, preservatives, skin conditioners, surfactants, and/or fragrances.
The non-aerosol shaving gel formulation of the invention provides the following features for the user:
(1) it will deposit a protective layer to enhance the natural action of skin oils;
(2) it will not emulsify protective skin oils unduly and thereby it will assist shaving without skin irritation or drying;
(3) it will contribute superior lubricity during use to minimize razor drag and skin irritation; and
(4) it can be used effectively by black males and others having a substantial number of bumps on their facial skin areas.
DETAILED DESCRIPTION OF INVENTION 1. COMPOSITION OF INVENTION
______________________________________                                    
               Percent by                                                 
               Weight                                                     
               Suitable                                                   
                      Preferred Optimum                                   
______________________________________                                    
A.  Essential Components                                                  
1.  Crosslinked, neutralized                                              
                     0.2-5    0.5-1.5 0.8                                 
    Gantrez ® copolymer                                               
2.  Water-soluble Soap                                                    
                      3-15     5-10   8                                   
3.  Water              80-96.8                                            
                              88.5-94.5                                   
                                      91.2                                
B.  Preferred Components                                                  
1.  Lubricant         0-50    10-30   20                                  
2.  Humectant         0-34     9-25   16.6                                
3.  Emulsifier       0-5      0.5-2   1                                   
4.  Preservative     0-4      0.8-2   1                                   
5.  Surfactant        0-10    3-8     5                                   
6.  Fragrance        0-1      0.2-0.6 0.4                                 
______________________________________                                    
When one or more of the preferred components are present in the composition, the amount of water therein is reduced accordingly.
2. DESCRIPTION OF COMPONENTS OF COMPOSITION Essential Components
A-1 - Crosslinked, Neutralized Gantrez® Copolymer
The crosslinked, neutralized Gantrez® copolymer component of the composition of the invention is a maleic anhydride-C1 -C5 alkyl vinyl ether copolymer neutralized with sodium hydroxide or potassium hydroxide. A preferred crosslinked Gantrez® is a copolymer of maleic anhydride and methyl vinyl ether crosslinked with about 1 to about 5 mole percent based on the monovinyl alkyl ether of a crosslinking agent. Suitable crosslinking agents include 1,9-decadiene, 1,7-octadiene, divinyl benzene, the divinyl ethers of an aliphatic diol acrylamides, acrylates and the like. Upon neutralization, such crosslinked copolymers provide gels of high viscosities and excellent stability.
The crosslinked, neutralized Gantrez® component suitably comprises about 0.2-5% by weight of the composition. Low percentages provide a relatively thin composition while high percentages will produce a relatively thick gel.
The crosslinked, neutralized Gantrez® component in the composition provides the resinous structure of the gel and forms a film on the skin both before and during shaving.
A-2 - Water-Soluble Soap
The soap component is a water-soluble salt of a higher fatty acid, i.e. C10 -C24 fatty acids. Soaps are well known in the art and may be prepared in any conventional manner. For example, soaps may be prepared by reacting a basic material such as triethanolamine directly with a higher fatty acid such as stearic, palmitic, myristic, oleic, coconut oil fatty acids, soya oil fatty acids, and mixtures of these acids.
The nature of the soap used, although not critical, has an effect on the type of gel produced. Preferred soaps include the water-soluble stearate and palmitate soaps, such as the potassium, ammonium, and soluble amine soaps of commercial stearic acid and palmitic acid. The triethanolamine and morpholine soaps of these acids are preferred. The product sold commercially as stearic acid is actually a mixture consisting primarily of stearic and palmitic acids. The term "stearates" is used herein to designate soaps of commercial stearic acid, although soaps of chemically pure stearic acid would be the equivalent for the purposes of this invention. The soaps may be made by neutralization of the appropriate higher fatty acid with suitable alkali, or may be introduced in the form of animal fats, such as tallow, or vegetable fats, such as palm oil, which are rich in the appropriate acid and which, when saponified, form soaps rich in the corresponding acid.
The amount of soap employed to form the gel generally depends upon the nature of the soap used. The low limit is the minimum amount which gives a satisfactory gel, and the upper limit is fixed either by economic considerations or by the amount which will form a suitable gel as the highest temperatures likely to be encountered in use. The beneficial effects of the instant invention are achieved to an optimum degree when the composition contains an appreciable amount of soap, such as specified within the preferred range.
The function of the soap in the composition of the invention is to fill up the pores of the resinous structure of the gel provided by the crosslinked Gantrez®. In addition, soap aids the wetting characteristics of the preparations described.
A-3 - Water
The water in the composition of the present invention is requisite for the preparation of a suitable gel having desirable shaving properties. It has been found that water (tap water, distilled water, deionized water, etc.) possesses adequate solubility for the soap and has the required compatibility with the resin to produce stable gels of the invention. In general, relatively small amounts of polar substances, such as lower molecular weight alcohols, methanol, ethanol, propanol, isopropanol, and the like may be used; the only requirement being that sufficient water be present to maintain the desired physical characteristic of the gel. Generally, the amount of water employed in the gel may be varied depending upon the properties desired in the final product. The amount of water employed depends on the nature of the soap and resin used.
It has been found, however, that at least about 80 percent and preferably from about 80 to about 95 percent by weight of the total gel composition should be water although higher amounts may be employed if desired, e.g., up to about 97 percent by weight of the total composition. The upper limit is the maximum amount that produces a satisfactory gel at the temperatures likely to be encountered in use, while the lower limit is fixed substantially by economic considerations.
Preferred Components
B-1 - Lubricant
The lubricant in the composition of the invention contributes to the comfort, closeness and speed of wet shaving. It is known in the art to use polysiloxanes and polysilicone fluids for their lubricating properties and these may be included in the composition of the invention for this purpose. Mineral oils, lanolin or isopropyl myristate also can be included to supplement the effects of the free fatty acid. Water-soluble polymers such as polyvinylpyrrolidone, sodium carboxymethyl cellulose or polyacrylic acid and its derivatives, can also improve lubrication and/or skin irritation caused by other compounds.
However, a preferred lubricant for use herein is disclosed in copending U.S. patent application, Ser. No. 510,017, filed Apr. 17, 1990, the entire disclosed of which is incorporated by reference herein. This lubricant composition includes individual droplets of a non-volatile silicone fluid encapsulated within a thin film of polyvinylpyrrolidone. These discrete droplets of encapsulated silicone fluid can be maintained as a stable dispersion or as a separate layer in an aqueous medium by controlling the viscosity of the solution. This composition is prepared by dispersing the non-volatile silicone fluid in an aqueous medium containing a vinylpyrrolidone monomers optionally including other monomers to be copolymerized therewith, and polymerizing the vinylpyrrolidone monomer in situ while maintaining the integrity of the silicone fluid dispersion. This results in the formation of a thin film (shell) of polyvinylpyrrolidone surrounding the individual dispersed particles of the silicone fluid (core).
Suitable non-volatile silicone fluids used in making these stabilized droplets may be either a polyalkyl siloxane, a polyaryl siloxane, a polyalkylaryl siloxane or a polyether siloxane copolymer, which are present at a level of from about 1.0% to about 18%. Preferably, the silicone fluid is present in an amount from about 2.0% to about 8.0%. Mixtures of silicone fluids also may be used so long as the final mixture is non-volatile. The dispersed silicone particles should also be insoluble in the medium. As used herein, the word "insoluble" means that it does not substantially dissolve in water and is essentially immiscible therewith.
Non-volatile polyalkylsiloxanes that may be used include, for example, polydimethylsiloxane with viscosities ranging from about 5-600,000 centistokes at 25° C. The siloxanes are available, for example, from the General Electric Company as the VISCASIL series and from Dow Corning as the Dow Corning 200 series. The viscosity can be measured by means of a glass capillary viscometer as set forth in Dow Corning Corporate Test Method CTM 0004 of July 20, 1970. Preferably, the viscosity ranges from about 350 centistokes to about 100,000 centistokes.
Non-volatile polyalkylarylsiloxanes that may be used include, for example, polymethylphenylsiloxanes having viscosities of from about 15-65 centistokes at 25° C. These siloxanes are available, for example, from the General Electric Company as SF 1075 methylphenyl fluid or from Dow Corning as 556 Cosmetic Grade Fluid. Additionally, poly(dimethylsiloxane)(diphenylsiloxane) copolymers having a viscosity in the range of from about 10-100,000 centistokes at 25° C. are useful.
Non-volatile polyethersiloxane copolymers suitable for use in the invention include, for example, a polypropylene oxide modified dimethylpolysiloxane, e.g., Dow Corning DC-1248, although ethylene oxide or mixtures of ethylene oxide and propylene oxide may also be used.
Suitable silicones are disclosed in U.S. Pat. No. 2,826,551, 3,964,500, 4,364,837, and British Patent No. 849,433 to Woolston. The disclosures of these patents are incorporated herein by reference. In addition, the disclosure Silicone Compounds distributed by Petrarch Systems Inc., 1984, is incorporated by reference. This literature provides an extensive listing of suitable silicone materials.
To prepare these stabilized silicone fluid droplets, the silicone fluid is added to water and subjected to agitation or high speed dispersion so as to produce a fine dispersion of discrete silicone fluid droplets throughout the aqueous medium.
Thereafter, a vinylpyrrolidone monomer is added to the mixture, along with an appropriate initiator. If desired, an additional monomer for purposes of forming a copolymer may be added. Typical co-monomers include dimethylaminopropyl methacrylate, dimethylaminoethyl methacrylate, methacrylamidopropyltrimethylammonium chloride, acrylamide, and neutralized acrylic acid.
In addition, a suitable polymerization catalyst for vinylpyrrolidone is then added. Typical of these catalysts are t-butylperoctoate, t-butylperoxypivalate, and the like. Conventional catalysts for the polymerization of vinyl pyrrolidone are suitable.
Thereafter, the polymerization is carried out by maintaining the reaction mixture at a temperature in the range from about 55° to 85° C., preferably, from about 75° to 85° C., and most preferably, from about 78° to 82° C., for a period of time sufficient to produce the desired effect of providing a film about the discrete droplets of silicone fluid.
In a similar manner, as the viscosity of the solution of the medium is decreased by decreasing the amount of vinylpyrrolidone monomer in the initial mixture which results in a more dilute concentration of vinylpyrrolidone polymer in the ultimate mixture, the proclivity to form a separate layer of the discrete silicone fluid droplets is enhanced.
Generally, the amount of monomer to silicone fluid is in the range from about 95/5 to 5/95 on a weight basis. We have found that as the ratio becomes less than about 50/50, the production of a stable suspension is significantly decreased. As used herein, a "stable suspension" means that the discrete droplets of the silicone fluid remain suspended on standing for seven days at ambient temperature.
In order to produce a stable suspension, the amount of vinylpyrrolidone monomer to silicone fluid is preferably in the range from about 95/5 to 60/40. Most preferred is the range from about 90/10 to 80/20.
When the particle size of the dispersed droplets are in the range from about 45 to 450μ, a viscosity of about 12,000 cps is suitable to maintain a stable suspension. When the particle size of the droplets are in the range from about 10 to 100μ, stability can be obtained at a viscosity of approximately 6,000 cps.
Accordingly, a dispersion of a silicone fluid (Dimethicone) was prepared by adding 10 grams of Dimethicone having a viscosity of 100 cs to a reactor kettle in 400 grams of distilled water. The mixture was stirred at 300 to 400 rpm to disperse the Dimethicone into discrete small droplets. The system was purged with nitrogen for 30 minutes.
The mixture was then heated to 80° C. and 0.25 grams of t-butylperoctoate was added. This temperature was maintained for 30 minutes with continuous stirring of the mixture.
Thereafter, 90 grams of vinylpyrrolidone were added at one time and an additional 0.25 grams of t-butylperoctoate was added. The mixture was maintained at 80° C. for 6 to 8 hours with continuous stirring. The vinylpyrrolidone residual content was monitored and it was considered that the reaction was complete when residual content was less than 0.1%.
The product obtained was a dispersion of minute droplets of the silicone fluid which remained suspended in the medium as a 90%-10% PVP:silicone composite containing 20% solids, i.e. 20 g. composite in 80 g. of water.
B-2 - Humectant
Up to about 28% of a humectant is included in the composition to prevent premature drying out of the gel. The humectant also has the effect of making the gel softer.
Suitable humectants include polyols such as sorbitol, glycerol, propylene glycol, dipropylene glycol, 1,3-butylene glycol. Preferably a combination of up to about 28% by weight of sorbitol and up to about 8% by weight of propylene glycol is used in the composition of the invention.
B-3 - Emulsifier
The emulsifier or non-ionic surfactants that are useful for the purposes of the present invention are of the polyoxyethylene derivative type and are generally used in an amount equal to not more than 10% by weight of the composition.
Of special utility are ethers formed from long chain fatty alcohols and alkylene oxides. Typical of these are commercially available products sold under the designation Brij 30 and Brij 35 which are ethers formed by condensing lauryl alcohol with ethylene oxide. Brij 30 is a liquid, oily product identified as polyoxyethylene (4) lauryl ether. Brij 35, on the other hand, is a waxy, solid product designated as polyoxyethylene (23) lauryl ether. The numbers in parentheses indicate the number of oxyethylene groups in each polyether.
B-4 - Preservative
Any suitable preservative may be used in the composition of the invention. A preferred preservative is Germaben® sold by the Sutton Labs Div. of GAF Corporation, which is a mixture of diazolidinyl urea, methyl and propyl paraben, and propylene glycol.
B-5 - Surfactant
Certain surface active agents, usually called wetting agents, or surfactants, may also be used as the soap ingredient. The wetting agents so employed preferably are anionic or non-ionic in character. They should be appreciably soluble in the aqueous components of the gel and of the type that produce foam in water solution. Examples of such agents are triethanolamine lauryl sulfate, sodium lauryl sulfate, sodium dodecyl benzene sulfonate, water-soluble polyoxyethylene ethers of alkyl-substituted phenols, and water-soluble polyoxyethylene cetyl ethers,. Numerous anionic and nonionic wetting agents suitable for the purposes of the present invention are described in detail in McCutcheon's "Emulsifiers & Detergents Annual," 1967. Although not essential to the invention, in some cases it may be desirable to add minor concentrations of a wetting agent to the gel as a supplement to the water-soluble soaps described above. the wetting agent has been found to be effective in removing oily residue from the skin and in facilitating rinsing the lather from the skin. When thus added to the composition as a soap supplement, the surfactant or wetting agent should be used in minor concentrations, preferably from about 3.0 percent to about 8 percent by weight of the gel.
A preferred surfactant is a non-ionic surfactant, such as Igepal® CO-630 (9 mole ethylene oxide), which is a preferred component in the composition of the invention.
COMPOSITION OF INVENTION
______________________________________                                    
Components            % by Weight                                         
______________________________________                                    
A-1. Crosslinked Gantrez ® (GAF)                                      
                          0.8                                             
     Sodium Hydroxide, 10%                                                
                          2.5                                             
2.   Palmitic Acid        5.8                                             
     Stearic Acid, T.P.   2.0                                             
     Triethanolamine, 98% 4.2                                             
3.   Deionized Water      44.3                                            
B-1. PVP-4 Silicone Composite, 90/10,                                     
                          20.0                                            
     20% solids                                                           
2.   a. Sorbitol, 70%     10.0                                            
     b. Propylene glycol  3.0                                             
3.   Brij 58              1.0                                             
4.   Germaben, II-E       1.0                                             
5.   Igepal CO-630        5.0                                             
6.   Fragrance            0.4                                             
                          100.0                                           
______________________________________                                    
The composition is prepared by adding A-1 in A-3 to A-2, heating to 60°-70° C. for 5-10 minutes, cooling to 35°-40° C. with constant mixing, and then adding B-1 to B-6.
NOTES
A-1 is a polyvinylmethylether-maleic anhydride copolymer.
B-1 is prepared according to the example above.
B-4 is a methylparaben-propylparaben.
B-5 is a nonoxynol.
When the composition above is used as a shaving preparation it is found that it provides a protective film on the skin which promotes effective razor glide, superior lubricity and a non-irritating feel on the skin, creaminess, and body, in a non-aerosol shaving gel which is convenient to use.

Claims (16)

What is claimed is:
1. A non-aerosol shaving gel composition consisting essentially of about 0.2-5% by weight of a crosslinked, neutralized maleic anhydride-C1 -C5 alkyl vinyl ether copolymer, about 3-15% by wt. of a soap component which is a water-soluble salt of a higher fatty acid C10 -C24 water-soluble soap, and about 80-97% by weight of water.
2. A non-aerosol shaving gel composition according to claim 1 which consists essentially of about 0.5-1.5% by weight of said copolymer, about 5-10% by weight of said soap, and about 88-95% by weight of water.
3. A non-aerosol shaving gel composition according to claim 1 which consists essentially of about 0.8% by weight of said copolymer, about 8% by weight of said soap, and about 91.2% by weight of water.
4. A non-aerosol shaving gel composition consisting essentially of about 0.2-5% by weight of a crosslinked, neutralized maleic anhydride-C1 -C5 alkyl vinyl copolymer, about 3-15% by weight of a water-soluble soap, one or more of the following: a lubricant, a humectant, an emulsifier, a preservative, a surfactant and a fragrance, the remainder being water.
5. A non-aerosol shaving gel composition according to claim 4 which includes about 10-30% by weight of a PVP-silicone composite lubricant, about 9-25% by weight of a humectant, about 0.5-2% by weight of an emulsifier, about 0.8-2% by weight of a preservative, and about 3-8% by weight of a surfactant.
6. A non-aerosol shaving gel composition according to claim 5 consisting essentially of about 0.8% by weight of a crosslinked, neutralized maleic anhydride-C1 -C5 alkyl vinyl ether copolymer, and about 8% by weight of a water-soluble soap.
7. A non-aerosol shaving gel composition according to claim 5 wherein said copolymer is neutralized with sodium or potassium hydroxide, said soap is a water-soluble salt of a fatty acid, said PVP-silicone composite lubricant is a stable suspension of in situ polymerized vinyl pyrrolidone monomer in the presence of silicone fluid.
8. A non-aerosol shaving gel composition according to claim 7 wherein said silicone fluid is dimethyl siloxane polymers.
9. A non-aerosol shaving gel composition consisting essentially of about 0.5-15% by weight of a crosslinked, neutralized maleic anhydride-C1 -C5 alkyl vinyl ether copolymer, about 5-10% by weight of a soap component which is a water-soluble salt of a higher fatty acid C10 -C24 water-soluble soap, about 10-30% by weight of a lubricant, about 9-25% by weight of a humectant, about 0.5-2% by weight of an emulsifier, about 0.8-2% by weight of a preservative, about 3-8% by weight of a surfactant, the rest being water.
10. A non-aerosol shaving gel composition according to claim 9 which includes about 0.2-0.6% by weight of a fragrance.
11. A non-aerosol shaving gel composition according to claim 9 wherein said lubricant is a PVP-silicone composite
12. A non-aerosol shaving gel composition according to claim 9 wherein said soap is a mixture of palmitic and stearic acids.
13. A non-aerosol shaving gel composition according to claim 9 wherein said humectant is a mixture of sorbitol and propylene glycol.
14. A non-aerosol shaving gel composition according to claim 9 wherein said surfactant is a non-ionic surfactant.
15. A non-aerosol shaving gel composition according to claim 14 wherein said non-ionic surfactant is nonoxynol.
16. A non-aerosol shaving gel composition consisting essentially of about 0.8% by weight of a crosslinked, maleic anhydride-C1 -C5 alkyl vinyl ether, about 2.5% by weight of 10% sodium hydroxide, about 5.8% by weight of palmitic acid, about 2.0% by weight of stearic acid, about 4.2% by weight of 98% triethanolamine, about 20% by weight of a 90% PVP-10% silicone composite, 20% solids, about 10% by weight of 70% sorbitol, about 3.0% by weight of propylene glycol, about 1.0% by weight of polyethylene glycol ether of cetyl alcohol about 1.0% by weight of a mixture of diazolidinyl urea, methyl and propylparaben and propylene glycol about 5.0% by weight of ethoxylated alkylphenol with 9 moles of ethylene oxide about 0.4% by weight of a fragrance, and 44.3% by weight of water.
US07/540,990 1990-06-20 1990-06-20 Non-aerosol shaving gel Expired - Fee Related US5034220A (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US07/540,990 US5034220A (en) 1990-06-20 1990-06-20 Non-aerosol shaving gel
PCT/US1991/002945 WO1991019477A1 (en) 1990-06-20 1991-04-29 Non-aerosol shaving gel
CA002082829A CA2082829A1 (en) 1990-06-20 1991-04-29 Non-aerosol shaving gel
AU78511/91A AU7851191A (en) 1990-06-20 1991-04-29 Non-aerosol shaving gel
EP91909246A EP0581764A1 (en) 1990-06-20 1991-04-29 Non-aerosol shaving gel

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/540,990 US5034220A (en) 1990-06-20 1990-06-20 Non-aerosol shaving gel

Publications (1)

Publication Number Publication Date
US5034220A true US5034220A (en) 1991-07-23

Family

ID=24157737

Family Applications (1)

Application Number Title Priority Date Filing Date
US07/540,990 Expired - Fee Related US5034220A (en) 1990-06-20 1990-06-20 Non-aerosol shaving gel

Country Status (5)

Country Link
US (1) US5034220A (en)
EP (1) EP0581764A1 (en)
AU (1) AU7851191A (en)
CA (1) CA2082829A1 (en)
WO (1) WO1991019477A1 (en)

Cited By (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5130121A (en) * 1990-04-17 1992-07-14 Isp Investments Inc. Skin care compositions containing discrete microdroplets of an oil in water stabilized by in situ polymerization of water-soluble vinyl monomer
US5169623A (en) * 1990-04-17 1992-12-08 Isp Investments Inc. Conditioning hair care compositions
US5169622A (en) * 1990-04-17 1992-12-08 Isp Investments Inc. Hair and skin care compositions containing discrete microdroplets of an oil in water stabilized by in situ copolymerization of a water-soluble vinyl monomer and a water-soluble acryl comonomer
US5174992A (en) * 1991-12-11 1992-12-29 International Flavors & Fragrances Inc. Method for forming a solid phase shaving stick article
US5209925A (en) * 1991-12-11 1993-05-11 International Flavors & Fragrances Inc. Stick shave formulation and article employing same
US5248495A (en) * 1992-04-16 1993-09-28 The Procter & Gamble Company Post foaming shaving gel composition
EP0584877A2 (en) * 1992-08-24 1994-03-02 Colgate-Palmolive Company Viscoelastic personal care composition
US5340571A (en) * 1993-03-26 1994-08-23 The Gillette Company Non-aerosol shaving gel
FR2702958A1 (en) * 1993-03-24 1994-09-30 Oreal Cosmetic composition containing at least one nonionic surfactant of the alkylpolyglycoside and / or polyglycerolated type and at least one crosslinked copolymer of maleic anhydride / alkyl (C1-C5) vinyl ether.
US5409695A (en) * 1994-02-22 1995-04-25 Dow Corning Corporation Method of increasing deposition of silicone conditioner to hair
WO1996007395A1 (en) * 1994-09-07 1996-03-14 The Procter & Gamble Company Clear, thickened topical skin care composition with water-insoluble perfume
US5587156A (en) * 1996-04-18 1996-12-24 Critical Dimension, Incorporated Shaving compositions containing particulate additives
US5714135A (en) * 1996-03-18 1998-02-03 Chesebrough-Pond' S Usa Co., Division Of Conopco, Inc. Hair treatment compostion
EP0829259A1 (en) * 1996-09-04 1998-03-18 Warner-Lambert Company Foam/gel with microbeads and/or fine particles
US5849281A (en) * 1996-11-12 1998-12-15 S. C. Johnson & Son, Inc. Method of soap-free shaving
US5858343A (en) * 1997-01-31 1999-01-12 S. C. Johnson & Son, Inc. Post-foaming shaving gel including poly(ethylene oxide) and polyvinylpyrrolidone in a preferred range of weight ratios
WO1999016413A1 (en) * 1997-09-26 1999-04-08 Colgate-Palmolive Company Nonaerosol shave gel compositions
WO2003009823A2 (en) * 2001-07-26 2003-02-06 The Gillette Company Non-aerosol shaving gel
WO2004037225A3 (en) * 2002-10-25 2004-12-29 Foamix Ltd Cosmetic and pharmaceutical foam
US20040265240A1 (en) * 2003-04-28 2004-12-30 Foamix Ltd. Foamable iodine composition
US20050074414A1 (en) * 2002-10-25 2005-04-07 Foamix Ltd. Penetrating pharmaceutical foam
US6893631B1 (en) 2001-06-14 2005-05-17 Mitchell & Sons, Llc Shaving soap and aftershave gel and methods of use thereof
US20070020213A1 (en) * 2002-10-25 2007-01-25 Foamix Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US20070020304A1 (en) * 2002-10-25 2007-01-25 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US20090190001A1 (en) * 2008-01-25 2009-07-30 Cheimets Peter N Photon counting imaging system
US7645803B2 (en) 2005-05-09 2010-01-12 Foamix Ltd. Saccharide foamable compositions
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US8343945B2 (en) 2007-12-07 2013-01-01 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
US8618081B2 (en) 2009-10-02 2013-12-31 Foamix Ltd. Compositions, gels and foams with rheology modulators and uses thereof
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US8709385B2 (en) 2008-01-14 2014-04-29 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8795635B2 (en) 2006-11-14 2014-08-05 Foamix Ltd. Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US9072667B2 (en) 2009-07-29 2015-07-07 Foamix Pharmaceuticals Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US9167813B2 (en) 2009-07-29 2015-10-27 Foamix Pharmaceuticals Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US9320705B2 (en) 2002-10-25 2016-04-26 Foamix Pharmaceuticals Ltd. Sensation modifying topical composition foam
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
US9539208B2 (en) 2002-10-25 2017-01-10 Foamix Pharmaceuticals Ltd. Foam prepared from nanoemulsions and uses
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US9884017B2 (en) 2009-04-28 2018-02-06 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4495169A (en) * 1983-08-22 1985-01-22 Basf Wyandotte Corporation Aerosol gel shaving cream
GB2166150A (en) * 1984-10-30 1986-04-30 Gillette Co Delayed-foaming shaving gels
GB2167429A (en) * 1984-11-27 1986-05-29 Alan John Robertson Shaving gel and package
EP0259843A2 (en) * 1986-09-09 1988-03-16 S.C. Johnson & Son, Inc. Post-foaming gel with an unsaturated or non-linear dialkanolamide or a monoalkanolamide
US4744979A (en) * 1984-12-07 1988-05-17 Osipow Lloyd I Self-lather generating shaving composition
US4775530A (en) * 1987-01-06 1988-10-04 Perricone Nicholas V Method for treatment and prevention of pseudofolliculitis barbae
US4944939A (en) * 1987-12-14 1990-07-31 Moore Milton D Shaving preparation for treatment and prevention of PFB (Ingrown Hairs)
US4957732A (en) * 1988-12-29 1990-09-18 L'oreal Shaving composition for the skin based on polyorgano-siloxanes containing an acyloxyalkyl group and process for use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU70487A1 (en) * 1974-07-08 1976-05-31
US4495168A (en) * 1983-08-22 1985-01-22 Basf Wyandotte Corporation Aerosol gel
US4501834A (en) * 1983-12-22 1985-02-26 Colgate-Palmolive Company Gels formed from anionic and cationic polymers

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4495169A (en) * 1983-08-22 1985-01-22 Basf Wyandotte Corporation Aerosol gel shaving cream
GB2166150A (en) * 1984-10-30 1986-04-30 Gillette Co Delayed-foaming shaving gels
GB2167429A (en) * 1984-11-27 1986-05-29 Alan John Robertson Shaving gel and package
US4744979A (en) * 1984-12-07 1988-05-17 Osipow Lloyd I Self-lather generating shaving composition
EP0259843A2 (en) * 1986-09-09 1988-03-16 S.C. Johnson & Son, Inc. Post-foaming gel with an unsaturated or non-linear dialkanolamide or a monoalkanolamide
US4775530A (en) * 1987-01-06 1988-10-04 Perricone Nicholas V Method for treatment and prevention of pseudofolliculitis barbae
US4944939A (en) * 1987-12-14 1990-07-31 Moore Milton D Shaving preparation for treatment and prevention of PFB (Ingrown Hairs)
US4957732A (en) * 1988-12-29 1990-09-18 L'oreal Shaving composition for the skin based on polyorgano-siloxanes containing an acyloxyalkyl group and process for use

Cited By (122)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5130121A (en) * 1990-04-17 1992-07-14 Isp Investments Inc. Skin care compositions containing discrete microdroplets of an oil in water stabilized by in situ polymerization of water-soluble vinyl monomer
US5169623A (en) * 1990-04-17 1992-12-08 Isp Investments Inc. Conditioning hair care compositions
US5169622A (en) * 1990-04-17 1992-12-08 Isp Investments Inc. Hair and skin care compositions containing discrete microdroplets of an oil in water stabilized by in situ copolymerization of a water-soluble vinyl monomer and a water-soluble acryl comonomer
US5174992A (en) * 1991-12-11 1992-12-29 International Flavors & Fragrances Inc. Method for forming a solid phase shaving stick article
US5209925A (en) * 1991-12-11 1993-05-11 International Flavors & Fragrances Inc. Stick shave formulation and article employing same
US5248495A (en) * 1992-04-16 1993-09-28 The Procter & Gamble Company Post foaming shaving gel composition
EP0584877A3 (en) * 1992-08-24 1996-01-17 Colgate Palmolive Co Viscoelastic personal care composition
EP0584877A2 (en) * 1992-08-24 1994-03-02 Colgate-Palmolive Company Viscoelastic personal care composition
FR2702958A1 (en) * 1993-03-24 1994-09-30 Oreal Cosmetic composition containing at least one nonionic surfactant of the alkylpolyglycoside and / or polyglycerolated type and at least one crosslinked copolymer of maleic anhydride / alkyl (C1-C5) vinyl ether.
EP0617954A1 (en) * 1993-03-24 1994-10-05 L'oreal Cosmetic composition containing an alkylpolyglycoside and/or polyglycerol type nonionic surfactant and a maleic anhydride/alkyl(C1-C5) vinylether crosslinked copolymer
US5744147A (en) * 1993-03-24 1998-04-28 L'oreal Cosmetic composition containing at least one surface-active agent of the alkylpolyglycoside and/or polyglycerolated type and at least one crosslinked copolymer of maleic anhydride/(C1-C5) alkylvinyl ether
US5961994A (en) * 1993-03-24 1999-10-05 L'oreal Cosmetic composition containing at least one nonionic surface-active agent of the alkyl polyglycosides and/or polyglycerolated type and at least one crosslinked copolymer of maleic anhydride/ (C1 -C5) alkylvinyl ether
US5340571A (en) * 1993-03-26 1994-08-23 The Gillette Company Non-aerosol shaving gel
WO1994022415A1 (en) * 1993-03-26 1994-10-13 The Gillette Company Non-aerosol shaving gel
US5409695A (en) * 1994-02-22 1995-04-25 Dow Corning Corporation Method of increasing deposition of silicone conditioner to hair
WO1996007395A1 (en) * 1994-09-07 1996-03-14 The Procter & Gamble Company Clear, thickened topical skin care composition with water-insoluble perfume
US5714135A (en) * 1996-03-18 1998-02-03 Chesebrough-Pond' S Usa Co., Division Of Conopco, Inc. Hair treatment compostion
US5587156A (en) * 1996-04-18 1996-12-24 Critical Dimension, Incorporated Shaving compositions containing particulate additives
US5756081A (en) * 1996-04-18 1998-05-26 S. C. Johnson & Son, Inc. Shaving compositions containing particulate additives
EP0829259A1 (en) * 1996-09-04 1998-03-18 Warner-Lambert Company Foam/gel with microbeads and/or fine particles
US5849281A (en) * 1996-11-12 1998-12-15 S. C. Johnson & Son, Inc. Method of soap-free shaving
US5858343A (en) * 1997-01-31 1999-01-12 S. C. Johnson & Son, Inc. Post-foaming shaving gel including poly(ethylene oxide) and polyvinylpyrrolidone in a preferred range of weight ratios
US6352689B1 (en) * 1997-01-31 2002-03-05 S. C. Johnson & Son, Inc. Post-foaming shaving gel including poly (ethylene oxide) and polyvinylpyrrolidone in a preferred range of weight ratios
WO1999016413A1 (en) * 1997-09-26 1999-04-08 Colgate-Palmolive Company Nonaerosol shave gel compositions
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
US6893631B1 (en) 2001-06-14 2005-05-17 Mitchell & Sons, Llc Shaving soap and aftershave gel and methods of use thereof
WO2003009823A2 (en) * 2001-07-26 2003-02-06 The Gillette Company Non-aerosol shaving gel
US6627185B2 (en) 2001-07-26 2003-09-30 The Gillette Company Non-aerosol Shaving gel free of thickening and gelling agents
WO2003009823A3 (en) * 2001-07-26 2003-10-16 Gillette Co Non-aerosol shaving gel
US20050074414A1 (en) * 2002-10-25 2005-04-07 Foamix Ltd. Penetrating pharmaceutical foam
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US20070020213A1 (en) * 2002-10-25 2007-01-25 Foamix Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US20070020304A1 (en) * 2002-10-25 2007-01-25 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US11033491B2 (en) 2002-10-25 2021-06-15 Vyne Therapeutics Inc. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US8722021B2 (en) 2002-10-25 2014-05-13 Foamix Ltd. Foamable carriers
US10821077B2 (en) 2002-10-25 2020-11-03 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US20100040561A9 (en) * 2002-10-25 2010-02-18 Foamix Ltd. Penetrating pharmaceutical foam
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US10322085B2 (en) 2002-10-25 2019-06-18 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US9713643B2 (en) 2002-10-25 2017-07-25 Foamix Pharmaceuticals Ltd. Foamable carriers
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US8741265B2 (en) 2002-10-25 2014-06-03 Foamix Ltd. Penetrating pharmaceutical foam
US9622947B2 (en) 2002-10-25 2017-04-18 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US9539208B2 (en) 2002-10-25 2017-01-10 Foamix Pharmaceuticals Ltd. Foam prepared from nanoemulsions and uses
US8435498B2 (en) 2002-10-25 2013-05-07 Foamix Ltd. Penetrating pharmaceutical foam
US9492412B2 (en) 2002-10-25 2016-11-15 Foamix Pharmaceuticals Ltd. Penetrating pharmaceutical foam
WO2004037225A3 (en) * 2002-10-25 2004-12-29 Foamix Ltd Cosmetic and pharmaceutical foam
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US8840869B2 (en) 2002-10-25 2014-09-23 Foamix Ltd. Body cavity foams
US9320705B2 (en) 2002-10-25 2016-04-26 Foamix Pharmaceuticals Ltd. Sensation modifying topical composition foam
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US8119106B2 (en) 2003-04-28 2012-02-21 Foamix Ltd Foamable iodine compositions
US20040265240A1 (en) * 2003-04-28 2004-12-30 Foamix Ltd. Foamable iodine composition
US8486375B2 (en) 2003-04-28 2013-07-16 Foamix Ltd. Foamable compositions
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8114385B2 (en) 2003-08-04 2012-02-14 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US8703105B2 (en) 2003-08-04 2014-04-22 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US9636405B2 (en) 2003-08-04 2017-05-02 Foamix Pharmaceuticals Ltd. Foamable vehicle and pharmaceutical compositions thereof
US8362091B2 (en) 2003-08-04 2013-01-29 Foamix Ltd. Foamable vehicle and pharmaceutical compositions thereof
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9101662B2 (en) 2003-08-04 2015-08-11 Foamix Pharmaceuticals Ltd. Compositions with modulating agents
US8518378B2 (en) 2003-08-04 2013-08-27 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US9050253B2 (en) 2003-08-04 2015-06-09 Foamix Pharmaceuticals Ltd. Oleaginous pharmaceutical and cosmetic foam
US7645803B2 (en) 2005-05-09 2010-01-12 Foamix Ltd. Saccharide foamable compositions
US9682021B2 (en) 2006-11-14 2017-06-20 Foamix Pharmaceuticals Ltd. Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8795635B2 (en) 2006-11-14 2014-08-05 Foamix Ltd. Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US10369102B2 (en) 2007-08-07 2019-08-06 Foamix Pharmaceuticals Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US11103454B2 (en) 2007-08-07 2021-08-31 Vyne Therapeutics Inc. Wax foamable vehicle and pharmaceutical compositions thereof
US9662298B2 (en) 2007-08-07 2017-05-30 Foamix Pharmaceuticals Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
US9161916B2 (en) 2007-12-07 2015-10-20 Foamix Pharmaceuticals Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
US8900553B2 (en) 2007-12-07 2014-12-02 Foamix Pharmaceuticals Ltd. Oil and liquid silicone foamable carriers and formulations
US9549898B2 (en) 2007-12-07 2017-01-24 Foamix Pharmaceuticals Ltd. Oil and liquid silicone foamable carriers and formulations
US9795564B2 (en) 2007-12-07 2017-10-24 Foamix Pharmaceuticals Ltd. Oil-based foamable carriers and formulations
US8343945B2 (en) 2007-12-07 2013-01-01 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US11433025B2 (en) 2007-12-07 2022-09-06 Vyne Therapeutics Inc. Oil foamable carriers and formulations
US8709385B2 (en) 2008-01-14 2014-04-29 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
US7961224B2 (en) 2008-01-25 2011-06-14 Peter N. Cheimets Photon counting imaging system
US20090190001A1 (en) * 2008-01-25 2009-07-30 Cheimets Peter N Photon counting imaging system
US9884017B2 (en) 2009-04-28 2018-02-06 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US10213384B2 (en) 2009-04-28 2019-02-26 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US10588858B2 (en) 2009-04-28 2020-03-17 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US10363216B2 (en) 2009-04-28 2019-07-30 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US9072667B2 (en) 2009-07-29 2015-07-07 Foamix Pharmaceuticals Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US9167813B2 (en) 2009-07-29 2015-10-27 Foamix Pharmaceuticals Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US11219631B2 (en) 2009-07-29 2022-01-11 Vyne Pharmaceuticals Inc. Foamable compositions, breakable foams and their uses
US10092588B2 (en) 2009-07-29 2018-10-09 Foamix Pharmaceuticals Ltd. Foamable compositions, breakable foams and their uses
US9572775B2 (en) 2009-07-29 2017-02-21 Foamix Pharmaceuticals Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US10350166B2 (en) 2009-07-29 2019-07-16 Foamix Pharmaceuticals Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US10265404B2 (en) 2009-10-02 2019-04-23 Foamix Pharmaceuticals Ltd. Compositions, gels and foams with rheology modulators and uses thereof
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US10086080B2 (en) 2009-10-02 2018-10-02 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10213512B2 (en) 2009-10-02 2019-02-26 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10322186B2 (en) 2009-10-02 2019-06-18 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10029013B2 (en) 2009-10-02 2018-07-24 Foamix Pharmaceuticals Ltd. Surfactant-free, water-free formable composition and breakable foams and their uses
US10137200B2 (en) 2009-10-02 2018-11-27 Foamix Pharmaceuticals Ltd. Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US9675700B2 (en) 2009-10-02 2017-06-13 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US8865139B1 (en) 2009-10-02 2014-10-21 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US8618081B2 (en) 2009-10-02 2013-12-31 Foamix Ltd. Compositions, gels and foams with rheology modulators and uses thereof
US10517882B2 (en) 2009-10-02 2019-12-31 Foamix Pharmaceuticals Ltd. Method for healing of an infected acne lesion without scarring
US10238746B2 (en) 2009-10-02 2019-03-26 Foamix Pharmaceuticals Ltd Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US10610599B2 (en) 2009-10-02 2020-04-07 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10821187B2 (en) 2009-10-02 2020-11-03 Foamix Pharmaceuticals Ltd. Compositions, gels and foams with rheology modulators and uses thereof
US8992896B2 (en) 2009-10-02 2015-03-31 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10835613B2 (en) 2009-10-02 2020-11-17 Foamix Pharmaceuticals Ltd. Compositions, gels and foams with rheology modulators and uses thereof
US10463742B2 (en) 2009-10-02 2019-11-05 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10946101B2 (en) 2009-10-02 2021-03-16 Vyne Therapeutics Inc. Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US10967063B2 (en) 2009-10-02 2021-04-06 Vyne Therapeutics Inc. Surfactant-free, water-free formable composition and breakable foams and their uses
US8945516B2 (en) 2009-10-02 2015-02-03 Foamix Pharmaceuticals Ltd. Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US8871184B2 (en) 2009-10-02 2014-10-28 Foamix Ltd. Topical tetracycline compositions
US10849847B2 (en) 2016-09-08 2020-12-01 Foamix Pharamaceuticals Ltd. Compositions and methods for treating rosacea and acne
US11324691B2 (en) 2016-09-08 2022-05-10 Journey Medical Corporation Compositions and methods for treating rosacea and acne
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne

Also Published As

Publication number Publication date
AU7851191A (en) 1992-01-07
CA2082829A1 (en) 1991-12-21
WO1991019477A1 (en) 1991-12-26
EP0581764A4 (en) 1993-08-02
EP0581764A1 (en) 1994-02-09

Similar Documents

Publication Publication Date Title
US5034220A (en) Non-aerosol shaving gel
CA1297793C (en) Hair styling mousse
US5130121A (en) Skin care compositions containing discrete microdroplets of an oil in water stabilized by in situ polymerization of water-soluble vinyl monomer
AU671119B2 (en) Post foaming shaving gel composition
US4421769A (en) Skin conditioning composition
US5104643A (en) Shaving composition for the skin based on polyorgano-siloxanes containing a hydroxyalkyl group and process for use
EP1269974A1 (en) Hair styling compositions
CA1256381A (en) Water-in-volatile silicone emulsifier concentrates, water-in-volatile silicone emulsions that are useful in personal-care formulations and methods of making same
JP2002518423A (en) Hair styling composition
GB2151657A (en) Shaving cream gel
EP1725299A1 (en) Shaving compositions
EP0714279B1 (en) Shaving composition
CA2080014C (en) Preparation of discrete microdroplets of an oil in water stabilized by in situ polymerization of a water-soluble vinyl monomer
JP2588845B2 (en) Cosmetic composition in the form of an aqueous gel
DE69930277T2 (en) HAIR FORMING COMPOSITION
US6916468B2 (en) Post-foaming shave gel
US3314857A (en) Shaving assistant composition
GB2325936A (en) Aerosol shaving foam
CA2165762A1 (en) Water in oil emulsifiers and emulsions made with them
EP1372589B1 (en) Post-foaming shave gel
JP2000514407A (en) Hair spray composition containing silicone copolyol
AU2002230942A1 (en) Post-foaming shave gel
KR100302060B1 (en) Sunburn preventive cosmetic composition
JPH09194338A (en) Hair cosmetic

Legal Events

Date Code Title Description
AS Assignment

Owner name: GAF CHEMICALS CORPORATION, NEW JERSEY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNORS:HELIOFF, MICHAEL W.;TAZI, MOHAMMED;LOGIN, ROBERT B.;AND OTHERS;REEL/FRAME:005347/0207;SIGNING DATES FROM 19900605 TO 19900613

AS Assignment

Owner name: CHASE MANHATTAN BANK (NATIONAL ASSOCIATION), THE

Free format text: SECURITY INTEREST;ASSIGNOR:GAF CHEMICALS CORPORATION, A CORP. OF DE;REEL/FRAME:005604/0020

Effective date: 19900917

AS Assignment

Owner name: CREATIVE TECHNOLOGIES GROUP, INC.

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:GAF CHEMICALS CORPORATION, A CORPORATION OF DE;REEL/FRAME:005732/0957

Effective date: 19910503

AS Assignment

Owner name: VERONA INC. A DE CORP.

Free format text: CHANGE OF NAME;ASSIGNOR:CREATIVE TECHNOLOGIES GROUP, INC.;REEL/FRAME:006163/0859

Effective date: 19920424

AS Assignment

Owner name: GAF BUILDING MATERIALS CORPORATION

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:CHASE MANHATTAN BANK, THE (NATIONAL ASSOCIATION);REEL/FRAME:006243/0208

Effective date: 19920804

Owner name: SUTTON LABORATORIES, INC.

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:CHASE MANHATTAN BANK, THE (NATIONAL ASSOCIATION);REEL/FRAME:006243/0208

Effective date: 19920804

Owner name: GAF CHEMICALS CORPORATION

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:CHASE MANHATTAN BANK, THE (NATIONAL ASSOCIATION);REEL/FRAME:006243/0208

Effective date: 19920804

FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

FPAY Fee payment

Year of fee payment: 4

REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
FP Lapsed due to failure to pay maintenance fee

Effective date: 19990723

STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362